Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Slow-release Carvedilol in HFpEF (CARE-preserved HF)
NCT05553314Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Nov 2021
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol in heart failure with preserved ejection fraction (HFpEF), sponsored by Seoul National University Bundang Hospital. Started Nov 2021; status: completed.
02
Drugs
carvedilol
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT05553314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05553314.